Related Experiment Videos
Glucose-induced hyperkalaemia: A hazard for diabetics?
Lancet (London, England)
|April 1, 1978
Summary
Intravenous glucose can paradoxically increase plasma potassium in insulin-deprived diabetics, unlike in non-diabetics. This finding suggests caution when using glucose injections as a therapeutic test for comatose diabetic patients.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Clinical Chemistry
Background:
- Intravenous glucose administration is sometimes used as a diagnostic test in comatose diabetic patients.
- The physiological response to glucose in insulin-deprived diabetics requires further investigation, particularly concerning electrolyte balance.
Purpose of the Study:
- To investigate the effect of oral glucose administration on plasma potassium levels in insulin-dependent diabetics who have withheld insulin.
- To compare the response in diabetics with that of non-diabetic individuals.
Main Methods:
- Eight insulin-dependent diabetics withheld insulin for 14-26 hours before receiving 50g of oral glucose.
- Plasma potassium and osmolality were measured before and after glucose intake.
- Non-diabetic controls underwent the same glucose challenge.
Main Results:
- A prompt rise in plasma potassium and plasma osmolality was observed in insulin-deprived diabetics after glucose intake.
- In contrast, plasma potassium levels decreased in non-diabetic controls following glucose administration.
- The observed potassium increase in diabetics may be linked to osmotic and hormonal factors.
Conclusions:
- Oral glucose can induce a paradoxical rise in plasma potassium in insulin-deprived diabetics.
- This effect may have clinical significance, warranting caution or discontinuation of intravenous glucose as a therapeutic test in this population.